Previous product
Back to products
Inlyta (axitinib)
CHF839.80
Next product
Zynlonta (loncastuximab tesirine-lpyl)
CHF27,746.55
Jemperli (dostarlimab)
CHF19,355.72
Jemperli (dostarlimab) is a prescription medicine used to treat:
- Certain types of endometrial cancer (cancer of the womb) that are advanced or recurrent.
- Certain types of recurrent or advanced solid tumours.
Category: Oncology
Reviews
There are no reviews yet.